CYTEK BIOSCIENCES, INC. Other Noncash Income (Expense)
CYTEK BIOSCIENCES, INC. (CTKB) reported Other Noncash Income (Expense) of -$1.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$1.59M.
- CYTEK BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$236.00K.
- CYTEK BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2025-06-30 was $0.00.
- CYTEK BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2025-03-31 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month |
|---|---|---|
| 2026-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.82M 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$236.00K 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |